But companies developing cancer vaccines and other mRNA treatments are still raising moneyLife science investors were already hesitant to fund companies developing messenger RNA vaccines. The Trump administration’s recent decision to halt nearly $500 million in funding for mRNA vaccine research has only made things worse.The situation isn’t as dire, however, for companies working on […]
